Product
PolyICLC
2 clinical trials
3 indications
Indication
MelanomaIndication
Ocular melanomaIndication
Uveal melanomaClinical trial
Enhanced Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists in Patients With MelanomaStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Pilot Evaluation of Focused Ultrasound Ablation and Intratumoral PolyICLC in Patients With Regionally Advanced Resectable Melanoma Who Are Receiving Neoadjuvant ImmunotherapyStatus: Not yet recruiting, Estimated PCD: 2026-08-01